MT-ND5 pseudogene 16 (MTND5P16)

MT-ND5 pseudogene 16 (MTND5P16) is a nuclear pseudogene corresponding to the mitochondrial gene MT-ND5, which encodes a subunit (NADH dehydrogenase 5) of mitochondrial respiratory chain complex I. As a pseudogene, MTND5P16 does not code for a functional protein and does not participate in mitochondrial electron transport or cellular bioenergetics. It has no established biological function, disease role, or utility as a drug target or clinical biomarker[4][8]. Its canonical mitochondrial parent, MT-ND5, is associated with oxidative phosphorylation, and mutations in MT-ND5 (not MTND5P16) have been linked to mitochondrial pathologies such as MELAS syndrome and Leigh syndrome, but these disease associations do **not** apply to the pseudogene[1][9]. MTND5P16 serves, at most, as a genomic reference or background sequence in genomics studies, and improper identification or confusion with the functional gene could be problematic in research or clinical contexts. Key Points: - MTND5P16 is a **pseudogene**, not an active gene or therapeutic target[4][8]. - It is sometimes misleadingly included in gene/disease searches due to homology with functional MT-ND5 but does not share its functions or disease links[4][8]. - There are **no known drugs, mechanisms of action, or biomarkers associated with MTND5P16**. - It should **not** be considered a receptor, enzyme, transporter, or other canonical drug target class. "MT-ND5" and "MT-ND5 pseudogene 16" are distinct; only the former is biologically active and clinically relevant.

Other names

MTND5P16MT-ND5 pseudogene 16mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5 pseudogene 16